This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Germer, J. J.
Right arrow Articles by Yao, J. D. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Germer, J. J.
Right arrow Articles by Yao, J. D. C.

 Previous Article  |  Next Article 

Journal of Clinical Microbiology, February 2006, p. 318-323, Vol. 44, No. 2
0095-1137/06/$08.00+0     doi:10.1128/JCM.44.2.318-323.2006
Copyright © 2006, American Society for Microbiology. All Rights Reserved.

Evaluation of the Invader Assay for Genotyping Hepatitis C Virus

Jeffrey J. Germer,1 David W. Majewski,1 Billy Yung,2 P. Shawn Mitchell,1 and Joseph D. C. Yao1*

Division of Clinical Microbiology, Mayo Clinic, Rochester, Minnesota,1 State University of New York Downstate Medical Center, Brooklyn, New York2

Received 10 January 2005/ Returned for modification 26 March 2005/ Accepted 23 November 2005

The Invader 1.0 assay (Invader HCV Genotyping Assay, version 1.0; Third Wave Technologies, Inc., Madison, WI) has been developed for the rapid differentiation of hepatitis C virus (HCV) genotypes 1 to 6 based on sequence variation within the HCV 5' noncoding (NC) region. In the present study, we evaluated the compatibility of Invader 1.0 with the COBAS MONITOR (COBAS AMPLICOR HCV MONITOR Test, version 2.0; Roche Molecular Systems, Inc., Branchburg, NJ), COBAS AMPLICOR (COBAS AMPLICOR Hepatitis C Virus Test, version 2.0; Roche Molecular Systems, Inc.), and COBAS TaqMan (COBAS TaqMan HCV Test; Roche Molecular Systems, Inc.) assays. The minimum HCV RNA titers required for successful HCV genotyping (≥90% success rate) were 1,000 IU/ml for COBAS MONITOR, 100 IU/ml for COBAS AMPLICOR, and 10 IU/ml for COBAS TaqMan. Invader 1.0 results obtained from unpurified COBAS TaqMan amplification products of 111 retrospectively selected clinical serum specimens (genotypes 1 to 6, with virus titers ranging from 15.1 to 2.1 x 107 IU/ml) showed 98% concordance with results obtained from the TRUGENE HCV 5' NC Genotyping Kit (Bayer HealthCare LLC, Tarrytown, NY), used in conjunction with COBAS AMPLICOR. Although the assay is sensitive, accurate, and easy to perform, additional optimization of the Invader 1.0 interpretive software (Invader Data Analysis Worksheet) may be necessary to reduce potential misidentification of HCV genotypes in low-titer specimens. In summary, Invader 1.0 is compatible with a variety of commercially available PCR-based HCV 5' NC region amplification assays and is suitable for routine HCV genotyping in clinical laboratories.

* Corresponding author. Mailing address: Division of Clinical Microbiology, Hilton 4-60, Mayo Clinic, 200 First Street S.W., Rochester, MN 55905. Phone: (507) 284-2255. Fax: (507) 284-4272. E-mail: jdcyao{at}mayo.edu.

Journal of Clinical Microbiology, February 2006, p. 318-323, Vol. 44, No. 2
0095-1137/06/$08.00+0     doi:10.1128/JCM.44.2.318-323.2006
Copyright © 2006, American Society for Microbiology. All Rights Reserved.



This article has been cited by other articles:

  • Schutzbank, T. E., Sefers, S. E., Kahmann, N., Li, H., Tang, Y.-W. (2006). Comparative evaluation of three commercially available methodologies for hepatitis C virus genotyping.. J. Clin. Microbiol. 44: 3797-3798 [Abstract] [Full Text]  


Copyright © 2009 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»